Novo Nordisk
NVO
#107
Rank
โ‚น15.445 T
Marketcap
โ‚น3,504
Share price
-2.70%
Change (1 day)
-17.88%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2026 (TTM): โ‚น2.144 Trillion

According to Novo Nordisk's latest financial reports the company's current earnings are โ‚น51.43 Billion. In 2025 the company made an earning of โ‚น1.942 Trillion, an increase over its 2024 earnings that were of โ‚น1.827 Trillion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น2.144 T10.43%
2025 โ‚น1.942 T6.28%
2024 โ‚น1.827 T28.01%
2023 โ‚น1.427 T57.81%
2022 โ‚น904.64 B5.24%
2021 โ‚น859.63 B12.38%
2020 โ‚น764.92 B13.11%
2019 โ‚น676.27 B-3.45%
2018 โ‚น700.43 B1.88%
2017 โ‚น687.48 B4.3%
2016 โ‚น659.12 B10.32%
2015 โ‚น597.45 B7.47%
2014 โ‚น555.94 B3.4%
2013 โ‚น537.65 B19.09%
2012 โ‚น451.48 B15.58%
2011 โ‚น390.63 B16.58%
2010 โ‚น335.08 B25.66%
2009 โ‚น266.66 B10.68%
2008 โ‚น240.94 B55.82%
2007 โ‚น154.63 B7.02%
2006 โ‚น144.48 B19.05%
2005 โ‚น121.36 B10.55%
2004 โ‚น109.78 B
2002 โ‚น72.63 B-14.39%
2001 โ‚น84.83 B-52.82%
2000 โ‚น179.79 B250%
1999 โ‚น51.37 B31.21%
1998 โ‚น39.15 B34.31%
1997 โ‚น29.14 B11.46%
1996 โ‚น26.15 B9.03%
1995 โ‚น23.98 B-3.15%
1994 โ‚น24.76 B-0.67%
1993 โ‚น24.93 B45.38%
1992 โ‚น17.14 B-13.81%
1991 โ‚น19.89 B37.12%
1990 โ‚น14.50 B-0.79%
1989 โ‚น14.62 B26.2%
1988 โ‚น11.58 B24.97%
1987 โ‚น9.27 B-0.9%
1986 โ‚น9.35 B-7.78%
1985 โ‚น10.14 B24.87%
1984 โ‚น8.12 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น645.65 B-69.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น3.221 T 51.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น721.63 B-66.12%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚น1.050 T-50.70%๐Ÿ‡บ๐Ÿ‡ธ USA